Burkhart Erin
SEC CIK 1927648 · EDGAR
BoughtSold
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-23 16:17 | 2026-09-22 | GILD | Gilead Sciences | Burkhart Erin | SVP, Controllership | M - OptEx | — | +2,223 | 2,223 | New | — |
| D | 2026-09-23 16:17 | 2026-09-22 | GILD | Gilead Sciences | Burkhart Erin | SVP, Controllership | F - Tax | $152.67 | -768 | 1,455 | -35% | -$117.3K |
| 2025-05-20 | 2025-05-19 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | F - Tax | $59.27 | -996 | 16.0K | -6% | -$59.0K | |
| 2025-05-20 | 2025-05-20 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | S - Sale | $59.31 | -1,786 | 14.2K | -11% | -$105.9K | |
| 2025-03-20 | 2025-03-19 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | S - Sale | $71.52 | -1,295 | 17.0K | -7% | -$92.6K | |
| D | 2025-03-18 | 2025-03-14 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | F - Tax | $69.44 | -823 | 12.3K | -6% | -$57.1K |
| D | 2025-03-18 | 2025-03-17 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | A - Grant | $0.00 | +5,970 | 18.3K | +49% | $0 |
| 2025-02-25 | 2025-02-24 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | S - Sale | $68.38 | -1,344 | 13.1K | -9% | -$91.9K | |
| 2024-08-15 | 2024-08-13 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | S - Sale | $90.00 | -714 | 14.4K | -5% | -$64.3K | |
| 2024-05-20 | 2024-05-17 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | F - Tax | $76.97 | -993 | 15.2K | -6% | -$76.4K | |
| 2024-04-12 | 2024-04-10 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | S - Sale | $90.00 | -2,286 | 16.2K | -12% | -$205.7K | |
| D | 2024-03-19 | 2024-03-18 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | F - Tax | $83.87 | -372 | 18.4K | -2% | -$31.2K |
| D | 2024-03-19 | 2024-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | A - Grant | $0.00 | +4,720 | 18.8K | +33% | $0 |
| 2023-05-18 | 2023-05-16 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | F - Tax | $92.02 | -796 | 14.1K | -5% | -$73.2K | |
| D | 2023-03-17 | 2023-03-15 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | A - Grant | $0.00 | +3,760 | 14.9K | +34% | $0 |
| D | 2022-05-18 | 2022-05-16 | BMRN | BIOMARIN PHARMACEUTICAL INC | Burkhart Erin | CAO, GVP | A - Grant | $0.00 | +11.1K | 11.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations